CD4 and breast cancer: In summary, CD4 + Th1 cells that expressed and secreted high levels of miR-19a-3p developed a TCM phenotype after 24 days of cell culture, and may contribute to the elevated levels of miR-19a-3p observed in the serum of patients with metastatic HER2 + breast cancer and a favorable prognosis.